Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multicenter evaluation of a whole-blood filter that saves platelets.
Paunovic D, van der Meer P, Kjeldsen-Kragh J, Kekomaki R, Larsson S, Greppi N, Porretti L, Balint B, Trkuljic M, Nedeljkovic N, Simonovic R, Massaro A, Labanca L, Kora S, Riggert J. Paunovic D, et al. Transfusion. 2004 Aug;44(8):1197-203. doi: 10.1111/j.1537-2995.2004.03350.x. Transfusion. 2004. PMID: 15265124
First clinical comparison of Nobori -Biolimus A9 eluting stents with Cypher- Sirolimus eluting stents: Nobori Core nine months angiographic and one year clinical outcomes.
Ostojic M, Sagic D, Beleslin B, Jung R, Perisic Z, Jagic N, Nedeljkovic M, Mangovski L, Milosavljevic B, Stojkovic S, Orlic D, Antonic Z, Miloradovic V, Topic D, Paunovic D. Ostojic M, et al. Among authors: paunovic d. EuroIntervention. 2008 Mar;3(5):574-9. doi: 10.4244/eijv3i5a103. EuroIntervention. 2008. PMID: 19608483
The pharmacokinetics of Biolimus A9 after elution from the Nobori stent in patients with coronary artery disease: the NOBORI PK study.
Ostojic M, Sagic D, Jung R, Zhang YL, Nedeljkovic M, Mangovski L, Stojkovic S, Debeljacki D, Colic M, Beleslin B, Milosavljevic B, Orlic D, Topic D, Karanovic N, Paunovic D, Christians U; NOBORI PK Investigators. Ostojic M, et al. Among authors: paunovic d. Catheter Cardiovasc Interv. 2008 Dec 1;72(7):901-8. doi: 10.1002/ccd.21775. Catheter Cardiovasc Interv. 2008. PMID: 19016466 Free PMC article. Clinical Trial.
Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study.
Danzi GB, Chevalier B, Urban P, Fath-Ordoubadi F, Carrie D, Wiemer M, Serra A, Wijns W, Kala P, Stabile A, Ruigomez JG, Sagic D, Laanmets P, Strupp G, West N, Paunovic D; NOBORI 2 Investigators. Danzi GB, et al. Among authors: paunovic d. EuroIntervention. 2012 May 15;8(1):109-16. doi: 10.4244/EIJV8I1A17. EuroIntervention. 2012. PMID: 22278136 Free article.
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.
Valgimigli M, Frigoli E, Heg D, Tijssen J, Jüni P, Vranckx P, Ozaki Y, Morice MC, Chevalier B, Onuma Y, Windecker S, Tonino PAL, Roffi M, Lesiak M, Mahfoud F, Bartunek J, Hildick-Smith D, Colombo A, Stanković G, Iñiguez A, Schultz C, Kornowski R, Ong PJL, Alasnag M, Rodriguez AE, Moschovitis A, Laanmets P, Donahue M, Leonardi S, Smits PC; MASTER DAPT Investigators. Valgimigli M, et al. N Engl J Med. 2021 Oct 28;385(18):1643-1655. doi: 10.1056/NEJMoa2108749. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449185 Clinical Trial.
Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus(R), paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial.
Chevalier B, Serruys PW, Silber S, Garcia E, Suryapranata H, Hauptmann K, Wijns W, Schuler G, Fath-Ordoubadi F, Worthley S, Thuesen L, Meredith I, Bressers M, Nagai H, Paunovic D. Chevalier B, et al. Among authors: paunovic d. EuroIntervention. 2007 Feb;2(4):426-34. EuroIntervention. 2007. PMID: 19755281
43 results